Mary Wozniak (she/her/hers)

Arkuda Therapeutics

Disclosure information not submitted.

Presentation(s):

• Powering high-throughput ELISA assays with recombinant technology

  Tuesday, February 6, 2024
  12:00 PM – 1:00 PM EST